{"entity":{"type":"insider","cik":"0001563615","url":"/insider/0001563615","json_url":"/insider/0001563615.json","name":"GERSHELL LELAND","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2013-05-21","last":"2016-03-18","span_basis":"filed_date"},"name_variants":[{"name":"GERSHELL LELAND","source":"filing","n_filings":9,"first_seen":"2013-05-21","last_seen":"2016-03-18"}],"transactions":[{"id":2089724,"accession":"0001144204-16-089007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-089007","line_url":"/filing/0001144204-16-089007#line-1","is_derivative":false,"issuer_cik":"0001133869","issuer_name":"CAPRICOR THERAPEUTICS, INC.","issuer_ticker":"CAPR","issuer_name_source":null,"issuer_url":"/issuer/0001133869","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":5040.0,"total_display":"5,040.00","total_whole":"5,040","shares_owned_after":2100.0,"shares_owned_after_display":"2,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-16","filed_date":"2016-03-18","scope":"insider"},{"id":8568483,"accession":"0001144204-15-056995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-056995","line_url":"/filing/0001144204-15-056995#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":5.825,"price_display":"5.82","price_state":"stated","total_value":2330.0,"total_display":"2,330.00","total_whole":"2,330","shares_owned_after":19260.0,"shares_owned_after_display":"19,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-28","filed_date":"2015-09-29","scope":"insider"},{"id":8701210,"accession":"0001144204-15-043097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-043097","line_url":"/filing/0001144204-15-043097#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":7500.0,"total_display":"7,500.00","total_whole":"7,500","shares_owned_after":18860.0,"shares_owned_after_display":"18,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-17","filed_date":"2015-07-17","scope":"insider"},{"id":8101018,"accession":"0001144204-15-007159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-007159","line_url":"/filing/0001144204-15-007159#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":29250.0,"total_display":"29,250.00","total_whole":"29,250","shares_owned_after":17860.0,"shares_owned_after_display":"17,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-09","scope":"insider"},{"id":5097341,"accession":"0001144204-13-049626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-049626","line_url":"/filing/0001144204-13-049626#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":1700.0,"total_display":"1,700.00","total_whole":"1,700","shares_owned_after":9330.0,"shares_owned_after_display":"9,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-06","filed_date":"2013-09-06","scope":"insider"},{"id":5288259,"accession":"0001144204-13-046285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-046285","line_url":"/filing/0001144204-13-046285#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3530.0,"shares_display":"3,530","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":8830.0,"shares_owned_after_display":"8,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-15","scope":"insider"},{"id":5549850,"accession":"0001144204-13-031730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-031730","line_url":"/filing/0001144204-13-031730#line-2","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":1123.5,"total_display":"1,123.50","total_whole":"1,124","shares_owned_after":5300.0,"shares_owned_after_display":"5,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-24","filed_date":"2013-05-28","scope":"insider"},{"id":5549848,"accession":"0001144204-13-031730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-031730","line_url":"/filing/0001144204-13-031730#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":374.5,"total_display":"374.50","total_whole":"375","shares_owned_after":5150.0,"shares_owned_after_display":"5,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-23","filed_date":"2013-05-28","scope":"insider"},{"id":9236365,"accession":"0001144204-13-031037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-031037","line_url":"/filing/0001144204-13-031037#line-1","is_derivative":false,"issuer_cik":"0001563615","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001563615","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":749.0,"total_display":"749.00","total_whole":"749","shares_owned_after":5100.0,"shares_owned_after_display":"5,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-21","filed_date":"2013-05-22","scope":"insider"},{"id":5351281,"accession":"0001144204-13-030776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-030776","line_url":"/filing/0001144204-13-030776#line-1","is_derivative":false,"issuer_cik":"0001430306","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001430306","owner_cik":"0001563615","owner_name":"GERSHELL LELAND","owner_display_name":"GERSHELL LELAND","owner_url":"/insider/0001563615","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":749.0,"total_display":"749.00","total_whole":"749","shares_owned_after":100100.0,"shares_owned_after_display":"100,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-21","filed_date":"2013-05-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133869","name":"CAPRICOR THERAPEUTICS, INC.","url":"/issuer/0001133869","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":1,"first_seen":"2016-03-18","last_seen":"2016-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001430306","name":"Tonix Pharmaceuticals Holding Corp.","url":"/issuer/0001430306","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2013-05-21","last_seen":"2015-09-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001563615","retrieved_at":"2026-08-23T15:42:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}